Abstract:Impaired macroautophagy/autophagy has been implicated in experimental and human pancreatitis. However, the transcriptional control governing the autophagy-lysosomal process in pancreatitis is largely unknown. We investigated the role and mechanisms of TFEB (transcription factor EB), a master regulator of lysosomal biogenesis, in the pathogenesis of experimental pancreatitis. We analyzed autophagic flux, TFEB nuclear translocation, lysosomal biogenesis, inflammation and fibrosis in GFP-LC3 transgenic mice, acinar cell-specific tfeb knockout (KO) and tfeb and tfe3 double-knockout (DKO) mice as well as human pancreatitis samples. We found that cerulein activated MTOR (mechanistic target of rapamycin kinase) and increased the levels of phosphorylated TFEB as well as pancreatic proteasome activities that led to rapid TFEB degradation. As a result, cerulein decreased the number of lysosomes resulting in insufficient autophagy in mouse pancreas. Pharmacological inhibition of MTOR or proteasome partially rescued cerulein-induced TFEB degradation and pancreatic damage. Furthermore, genetic deletion of tfeb specifically in mouse pancreatic acinar cells increased pancreatic edema, necrotic cell death, infiltration of inflammatory cells and fibrosis in pancreas after cerulein treatment. tfeb and tfe3 DKO mice also developed spontaneous pancreatitis with increased pancreatic trypsin activities, edema and infiltration of inflammatory cells. Finally, decreased TFEB nuclear staining was associated with human pancreatitis. In conclusion, our results indicate a critical role of impaired TFEB-mediated lysosomal biogenesis in promoting the pathogenesis of pancreatitis. Abbreviations: AC: acinar cell; AMY: amylase; ATP6V1A: ATPase, H+ transporting, lysosomal V1 subunit A; ATP6V1B2: ATPase, H+ transporting, lysosomal V1 subunit B2; ATP6V1D: ATPase, H+ transporting, lysosomal V1 subunit D; ATP6V1H: ATPase, H+ transporting, lysosomal V1 subunit H; AV: autophagic vacuole; CDE: choline-deficient, ethionine-supplemented; CLEAR: coordinated lysosomal expression and regulation; CQ: chloroquine; EIF4EBP1: eukaryotic translation initiation factor 4E binding protein 1; EM: electron microscopy; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; GFP: green fluorescent protein; H & E: hematoxylin and eosin; KO: knockout; LAMP1: lysosomal-associated membrane protein 1; MAP1LC3/LC3: microtubule associated protein 1 light chain 3; MAPK1/ERK2: mitogen-activated protein kinase 1; MTORC1: mechanistic target of rapamycin kinase complex 1; ND: normal donor; NEU: neutrophil; PPARGC1A/PGC1α: peroxisome proliferator-activated receptor, gamma, coactivator 1 alpha; RIPA: radio-immunoprecipitation; RPS6: ribosomal protein S6; SQSTM1/p62: sequestosome 1; TFEB: transcription factor EB; TM: tamoxifen; WT: wild-type; ZG: zymogen granule.

ATF6 aggravates acinar cell apoptosis and injury by regulating p53/AIFM2 transcription in Severe Acute Pancreatitis

ACLS4 could be a potential therapeutic target for severe acute pancreatitis

Lactate‐Dependent HIF1A Transcriptional Activation Exacerbates Severe Acute Pancreatitis Through the ACSL4/LPCAT3/ALOX15 Pathway Induced Ferroptosis

Deletion Of Xiap Reduces The Severity Of Acute Pancreatitis Via Regulation Of Cell Death And Nuclear Factor-Kappa B Activity

Deletion Of XIAP reduces the severity of acute pancreatitis via regulation of cell death and nuclear factor- κ B activity

Study of the Protective Effects of Dexamethasone on Ileum Mucosa Injury in Rats with Severe Acute Pancreatitis.

ATF6 Aggravates Apoptosis in Early Porcine Embryonic Development by Regulating Organelle Homeostasis under High-Temperature Conditions.

PFKFB3 controls acinar IP3R-mediated Ca2+ overload to regulate acute pancreatitis severity

The Antagonist Of The Jak-1/Stat-1 Signaling Pathway Improves The Severity Of Cerulein-Stimulated Pancreatic Injury Via Inhibition Of Nf-Kappa B Activity

Activation of AMPK ameliorates acute severe pancreatitis by suppressing pancreatic acinar cell necroptosis in obese mice models

Down-Regulation of Tumor Necrosis Factor-Associated Factor 6 is Associated with Progression of Acute Pancreatitis Complicating Lung Injury in Mice

Upregulation of PIAS1 Protects Against Sodium Taurocholate-Induced Severe Acute Pancreatitis Associated with Acute Lung Injury

Impaired TFEB-mediated Lysosomal Biogenesis Promotes the Development of Pancreatitis in Mice and is Associated with Human Pancreatitis.

Caspase Inhibitor Zvad-Fmk Protects Against Acute Pancreatitis-Associated Lung Injury Via Inhibiting Inflammation and Apoptosis

Inhibition Of Hypoxia-Inducible Factor-1 Alpha Alleviates Acinar Cell Necrosis In A Mouse Model Of Acute Pancreatitis

LincRNA-EPS Alleviates Severe Acute Pancreatitis by Suppressing HMGB1-triggered Inflammation in Pancreatic Macrophages

PRMT7-Dependent Transcriptional Activation of Hmgb2 Aggravates Severe Acute Pancreatitis by Promoting Acsl1-Induced Ferroptosis

Identification of novel immune-related targets mediating disease progression in acute pancreatitis

Extracellular SQSTM1 exacerbates acute pancreatitis by activating autophagy-dependent ferroptosis

Endoplasmic Reticulum Stress Promoted Acinar Cell Necroptosis in Acute Pancreatitis Through Cathepsinb-Mediated AP-1 Activation.

High-Fat Diet Aggravates the Intestinal Barrier Injury Via TLR4-RIP3 Pathway in a Rat Model of Severe Acute Pancreatitis